The short answer
The sources checked do not establish that Rhodiola rosea increases phenylephrine side effects or blood levels. Rhodiola can cause symptoms such as insomnia or headache on its own, but overlapping symptoms are not proof of an interaction. Review the exact products if you plan to use them together.
What this answer covers
Oral phenylephrine hydrochloride and Rhodiola rosea supplements. Findings for a particular commercial rhodiola extract or other medicines do not automatically apply to this pair. Nasal, eye and injected phenylephrine require separate assessment.
- Supplement or preparation
- Rhodiola rosea
- Medication ingredient
- phenylephrine
What symptoms can rhodiola cause by itself?
NCCIH lists headache, dizziness and insomnia among possible rhodiola adverse effects. Some of these also occur with cold medicines. If symptoms begin after combining products, the timing is useful to report, but it does not by itself identify an interaction or the responsible ingredient.
Does the drug-metabolism study apply here?
Thirteen volunteers took a commercial rhodiola product before a cocktail of test medicines. The study found a modest change in a losartan metabolite ratio, while other tested enzyme activities did not change significantly. Phenylephrine was not tested, so the result cannot establish higher phenylephrine levels.
Why not infer a general enzyme interaction?
Different medicines use different metabolic pathways. The inspected phenylephrine study describes sulfation and monoamine-oxidase metabolism; a rhodiola result involving a CYP2C9 probe is not enough to predict its response. Neither study tested the actual combination.
What is a useful next step?
Ask a pharmacist to check the exact rhodiola extract and all ingredients in the cold medicine. Mention troublesome insomnia, headache or palpitations and when they started. No evidence-based separation interval or rhodiola dose adjustment was established for this pair.
Evidence and practical considerations
Side effects & toxicity
A clinically important rhodiola/phenylephrine interaction was not established. Reported rhodiola symptoms and a CYP2C9 probe finding involving losartan do not demonstrate increased phenylephrine exposure or toxicity.
- Exact scope
- Oral phenylephrine hydrochloride and Rhodiola rosea supplements. Findings for a particular commercial rhodiola extract or other medicines do not automatically apply to this pair. Nasal, eye and injected phenylephrine require separate assessment. with oral phenylephrine hydrochloride supplying the exact phenylephrine active moiety, RxCUI 8163
- Medication form and route
- oral
- Timing or duration
- During co-use; source-specific durations are retained without inferring a universal safe duration.
What remains uncertain
- No direct pair study located. The small metabolism study tested other drugs and one rhodiola product; general symptom overlap neither confirms harm nor establishes safety.
Factors that may matter: rhodiola preparation; other ingredients in the supplement; phenylephrine route and co-formulation; baseline insomnia or headache.
Read the supporting source summaries
Source 1: regulatory product information
medicines.org.uk · Source check Sep 10, 2026
Population: People using this oral cold and flu combination product, age 16 years and older.
The product combines phenylephrine and caffeine, warns against excessive additional caffeine, and lists hypertension and heart disease among contraindications. Caffeine and phenylephrine adverse effects include palpitations and sleep-related symptoms.
How this applies: Exact phenylephrine active moiety and caffeine co-formulation. Botanical applicability is an inference only when the supplement actually supplies caffeine; other herb constituents and other phenylephrine routes are not evaluated.
Instructions apply to this finished oral product. They neither establish a universal caffeine threshold or spacing interval nor prove safety of isolated phenylephrine with supplements. Other ingredients confound extrapolation.
Source 2: government botanical evidence summary
nccih.nih.gov · Source check Sep 10, 2026
Population: People using Rhodiola rosea supplements.
Reported adverse effects include dizziness, headache and insomnia. Interaction reports concern losartan; phenylephrine is not identified.
How this applies: Supports symptom and product review while keeping the exact phenylephrine claim unconfirmed.
General botanical information and a different medicine do not establish a phenylephrine interaction. Absence of a listed interaction is not proof of safety.
Source 3: randomized crossover drug-metabolism probe study
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: Thirteen healthy volunteers.
The EXP3174/losartan ratio fell by 21%, consistent with a modest CYP2C9 effect; other tested enzyme activities did not change significantly.
How this applies: Rejects transferring a losartan/CYP2C9 observation to phenylephrine toxicity. The inspected phenylephrine study describes sulfation and monoamine-oxidase metabolism.
No phenylephrine; one product, small study, abstract only. A CYP-probe finding does not establish altered levels of a different medicine.
Source 4: randomized placebo-controlled crossover study
pmc.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: Twenty-eight healthy normotensive adults.
Cardiovascular tolerability was broadly comparable with placebo. Exposure increased more than proportionally with dose; individual concentrations varied substantially.
How this applies: Medication-only evidence prevents presenting every oral phenylephrine dose as inevitably raising blood pressure. It does not show that any supplement combination is safe.
Selected healthy participants, single doses, no supplement co-use. The authors state the design does not adequately assess proarrhythmic risk. Sponsor funded the study and authors were sponsor employees.
Research assessment: · Open full citations ↗
Review and change history
- Publication status
- Published research summary
- Clinical review
- Not yet recorded
| Date | Update |
|---|---|
| Article prepared | |
| Removed the implication of an established rhodiola-specific phenylephrine interaction. Added the actual probe drugs, modest CYP2C9 result and phenylephrine metabolism boundary. | |
| Research summary published |
Article revision: f456e7083fb7b103
This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.
Full citations require verification. Reading this answer and the source summaries does not.
Taking other supplements or medications?
Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.
Open the interaction checkerInformation, not medical advice. Do not change prescribed treatment based on this guide.